$BGNE BeiGene, Ltd. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BeiGene, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in BeiGene, Ltd.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
BeiGene, Ltd. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| AMGEN INC | 10% Owner | 18,778,273 | 674,515,566 | Dec 18 2020 | |||
| BAKER BROS ADVISORS LLC | Director | 10,418 | 374,215 | Dec 04 2020 | |||
| CB Biotech Investment Ltd | 10% Owner | 19,601,138 | 704,072,877 | Feb 09 2016 | |||
| Chen Timothy Yung-Cheng | Director | 2,200 | 79,024 | Aug 12 2020 | |||
| Glazer Donald W. | Director | 2,754,129 | 98,928,314 | Jun 03 2021 | |||
| Hillhouse Capital Management, Ltd. | 10% Owner | 39,726,779 | 1,426,985,902 | Feb 10 2016 | |||
| HOOPER ANTHONY C | Director | 0 | 0 | Jun 19 2020 | |||
| Huang Jane | CMO, Hematology | 1,500 | 53,880 | May 03 2021 | |||
| Li Ji | EVP and Gl. Head of Bus. Dev. | 10,000 | 359,200 | Mar 02 2018 | |||
| Liang Howard | CFO & Chief Strategy Officer | 1,400 | 50,288 | Jan 19 2021 | |||
| Malley Thomas | Director | 9,290 | 333,697 | Jun 19 2020 | |||
| Merck & Co., Inc. | 10% Owner | 7,942,314 | 285,287,919 | Feb 10 2016 | |||
| OYLER JOHN | Chief Executive Officer | 7,336,253 | 263,518,208 | Dec 15 2020 | |||
| Peterson Amy C. | CMO, Immuno-oncology | 9,859 | 354,135 | Dec 19 2018 | |||
| Sanders Corazon (Corsee) D. | Director | 0 | 0 | Aug 26 2020 | |||
| su Jingshyh S | Director | 0 | 0 | Jun 19 2020 | |||
| Tang Ke | Director | 0 | 0 | Apr 21 2017 | |||
| Wang Xiaodong | Director | 5,786,271 | 207,842,854 | Jun 21 2021 | |||
| Wu Xiaobin | President, COO & GM China | 0 | 0 | May 05 2021 | |||
| Yan Wendy Xiaojun | Sr. VP, Head of Reg. Affairs | 0 | 0 | Jul 15 2016 | |||
| Yang Jianxin | Sr. VP, Head of Clinical Dev. | 0 | 0 | Jul 15 2016 | |||
| Yi Qingqing | Director | 0 | 0 | Jun 18 2019 | |||
| Yuan RuiRong | Chief Medical Officer | 130,000 | 4,669,600 | Feb 09 2016 |